040B
Freaky Bodybuilder
- Lid sinds
- 3 aug 2015
- Berichten
- 5.199
- Waardering
- 9.088
- Lengte
- 1m80
- Massa
- 89kg
Zolang je maar niet op je mobiel pist.

Volg de onderstaande video samen om te zien hoe u onze site kunt installeren als een web-app op uw startscherm.
Notitie: Deze functie is mogelijk niet beschikbaar in sommige browsers.
Zolang je maar niet op je mobiel pist.

Test-e elke dag geeft nog een stabielere waarde, maar het word niet significant beter. Ik vind zelf dat je minimaal binnen 50% van de halveringstijd van het ester moet injecteren. Voor een prop ester is de halveringstijd 4 dagen en werkt om de dag dus ideaal. Een enanthaat ester heeft een halveringstijd van 10 dagen en is mijn mening dat je maximaal 5 dagen tussen elke injectie moet laten.Test e om de dag geeft nog stabielere waarde dan test p om de dag.
Test-e elke dag geeft nog een stabielere waarde, maar het word niet significant beter. Ik vind zelf dat je minimaal binnen 50% van de halveringstijd van het ester moet injecteren. Voor een prop ester is de halveringstijd 4 dagen en werkt om de dag dus ideaal. Een enanthaat ester heeft een halveringstijd van 10 dagen en is mijn mening dat je maximaal 5 dagen tussen elke injectie moet laten.
Belangrijker zijn de doses (mg/ml) waar je prikt (bil - arm - subq ), de bolus en hoe de substantie is klaargemaakt (carrier (olie) en oplosmiddelen etc).
The effect of steroid esters | JuicedMuscle.com
Influences on the halflife and potency of steroids | JuicedMuscle.com
I have never heard anyone provide an explanation for how this would work. The same quantity of the esterfied drug is inside the body with either injection spot. The only way for the drug to leave the body is to first enter the blood circulation, then having the ester removed by enzymes, and then to be metabolized and secreted by liver and kidneys. It's not like any of the drug could just magically disappear in the delts. The only difference between injection spots is how fast the esterfied drug enters the blood stream. So absent of any valid theoretical explanation, I would argue that there is some measurement error in the studies. But hey I'm biased since I'm too immobile to pin my glutesConclusies betreft inject spots zijn wel bizar.. Tot wel 30% meer effectiviteit van AAS wanneer je in de glute injecteert t.o.v. delts. Vind ik heel opmerkelijk.

I have never heard anyone provide an explanation for how this would work. The same quantity of the esterfied drug is inside the body with either injection spot. The only way for the drug to leave the body is to first enter the blood circulation, then having the ester removed by enzymes, and then to be metabolized and secreted by liver and kidneys. It's not like any of the drug could just magically disappear in the delts. The only difference between injection spots is how fast the esterfied drug enters the blood stream. So absent of any valid theoretical explanation, I would argue that there is some measurement error in the studies. But hey I'm biased since I'm too immobile to pin my glutes![]()
Test-e elke dag geeft nog een stabielere waarde, maar het word niet significant beter. Ik vind zelf dat je minimaal binnen 50% van de halveringstijd van het ester moet injecteren. Voor een prop ester is de halveringstijd 4 dagen en werkt om de dag dus ideaal. Een enanthaat ester heeft een halveringstijd van 10 dagen en is mijn mening dat je maximaal 5 dagen tussen elke injectie moet laten.
Injection site affects the steroids pharmacokinetics and therefore also it's effectivity. There isn't much substance on this, but there's a good paper detailing the pharmacokinetics (and to some extent the pharmacodynamics) of nandrolone depending on ester, injection site and oil volume: Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume. - PubMed - NCBII have never heard anyone provide an explanation for how this would work. The same quantity of the esterfied drug is inside the body with either injection spot. The only way for the drug to leave the body is to first enter the blood circulation, then having the ester removed by enzymes, and then to be metabolized and secreted by liver and kidneys. It's not like any of the drug could just magically disappear in the delts. The only difference between injection spots is how fast the esterfied drug enters the blood stream. So absent of any valid theoretical explanation, I would argue that there is some measurement error in the studies. But hey I'm biased since I'm too immobile to pin my glutes![]()
I took a quick look at the study. The finding that injection site influences plasma nandrolone levels is not statistically significant in a multivariate regression model (Neither were the coefficient estimates statistically significant for other dependent variables such as testosterone and inhibin levels). And the difference in AUC between deltoid and gluteus injection is only statistically significant at the 10% level in the empirical model. In their fitted model, the difference in AUC is significant, but given how many free parameters are in their model, that's basically a foregone conclusion.Injection site affects the steroids pharmacokinetics and therefore also it's effectivity. There isn't much substance on this, but there's a good paper detailing the pharmacokinetics (and to some extent the pharmacodynamics) of nandrolone depending on ester, injection site and oil volume: Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume. - PubMed - NCBI
My point is that the drug still has to go through the blood stream before being further metabolized and then secreted in urine. So it cannot disappear in the muscle tissue before entering the blood, and thus I don't see how AUC of the drug's plasma levels can vary much for different IM injection sites. Your article is mostly about the absorption of oral drugs into the blood stream, so I don't really see the connection to be honest.It's not like any of the drug could just magically disappear in the delts. ...
W Schänzer 1996:
Anabolic androgenic steroids (AAS) are misused to a high extent in sports by athletes to improve their physical performance. Sports federations consider the use of these drugs in sports as doping. The misuse of AAS is controlled by detection of the parent AAS (when excreted into urine) and (or) their metabolites in urine of athletes. I present a review of the metabolism of AAS. Testosterone
There are many excretion profiles available on the net. Studies from the fifties already found that excretion increased when people took T3, newer research also investigated other metabolism enhancers such as caffeine.. verrek ben ik alweer in het engels bezig en dat op een nederlands site ...lol..
I posted about here How to use oral anabolic steroids | JuicedMuscle.com
Erg vreemd dat die bron dat aangeeft, meerdere bronnen spreken deze toch tegen. Ik ga toch uit van 10 dagen voor het E ester
Erg vreemd dat die bron dat aangeeft, meerdere bronnen spreken deze toch tegen. Ik ga toch uit van 10 dagen voor het E ester
Erg vreemd dat die bron dat aangeeft, meerdere bronnen spreken deze toch tegen. Ik ga toch uit van 10 dagen voor het E ester
Why only look at the AUC? You'd mainly expect differences in other pharmacokinetic variables when looking whether or not injection site or carrier has any effect.I took a quick look at the study. The finding that injection site influences plasma nandrolone levels is not statistically significant in a multivariate regression model (Neither were the coefficient estimates statistically significant for other dependent variables such as testosterone and inhibin levels). And the difference in AUC between deltoid and gluteus injection is only statistically significant at the 10% level in the empirical model. In their fitted model, the difference in AUC is significant, but given how many free parameters are in their model, that's basically a foregone conclusion.
With the exception of AUC, all pharmacokinetic parameters were significantly different between groups.So the empirical evidence for differences in pharmacokinetics based on injection site is very weak.
Well, the release of an esterified steroid from the oily depot is determined by its partition coefficient, which is influenced by what directly borders the oily depot and thus also depends on the surface area the oil depot borders the surrounding tissue with. Imagine a perfect sphere, it's surface area bordering surrounding tissue will be much smaller than when the same volume of oil would form a layer exactly 1 molecule thick (which would yield the largest possible surface area).Furthermore, the paper provides no explanation of, or data for, how specifically the pharmacokinetics would differ. They did find that gluteal injections are associated with slower release kinetics than for deltoid injections, which they argue may be due to differences in blood flow and intramuscular fat deposits. In my mind, this is the only mechanism through which drug metabolism between the two groups may differ. But how exactly? No clue. And would that lead to a 30% difference in AUC plasma concentrations? Very unlikely.
You are referring to table 4?. 'Time of peak', 'Peak concentration', 'Mean residence time', 'Half-time', 'Duration' and 'Clearance' were all significantly different between groups in table 4. But I'm not sure what the null hypothesis there actually is. I reckon the null is that all 4 estimates are identical. So for example if there were only a difference between column 1 and 4, that would cause the low p value even when columns 3 and 4 are not significantly different statistically.Why only look at the AUC? You'd mainly expect differences in other pharmacokinetic variables when looking whether or not injection site or carrier has any effect.
With the exception of AUC, all pharmacokinetic parameters were significantly different between groups.
Komt er weer zo'n totale mong**lHalve waardetijd is een niet bestaand fenomeen, gewoon theoretisch

